Filing Flows › Amgen (AMGN) › Product sales revenue
Amgen (AMGN) Product sales revenue by quarter
Amgen's Product sales revenue was $9.9B in Q3 2026 (third quarter 2026), +4% from Q2 2026. Over the last 7 quarters it ranged from $7.9B (Q1 2025) to $9.9B (Q3 2026).
| Quarter | Product sales revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $9.9B | +4% | +8% |
| Q2 2026 | $9.5B | +16% | +9% |
| Q1 2026 | $8.2B | -12% | +4% |
| Q4 2025 | $9.4B | +3% | — |
| Q3 2025 | $9.1B | +4% | — |
| Q2 2025 | $8.8B | +11% | — |
| Q1 2025 | $7.9B | — | — |
Q3 2026 at a glance
Amgen, Q3 2026: revenue $10.4B (+8% year over year), operating margin 35.8%, net earnings $3.9B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
Questions
What is Amgen's Product sales revenue?
Amgen's Product sales revenue was $9.9B in Q3 2026 (third quarter 2026), +4% from Q2 2026.
How has Amgen's Product sales revenue changed?
Over the last 7 quarters it ranged from $7.9B (Q1 2025) to $9.9B (Q3 2026).